# Preventing Stroke Triggers in Children With Sickle Cell Anaemia in Mulago Hospital, Kampala (PREST ): a Randomized Control Trial

> **NCT03666806** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Makerere University** · enrollment: 150 (estimated)

## Conditions studied

- Preventing Stroke in Sickle Cell Anaemia

## Interventions

- **BIOLOGICAL:** Influenza vaccine

## Key facts

- **NCT ID:** NCT03666806
- **Lead sponsor:** Makerere University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-22
- **Primary completion:** 2019-09
- **Final completion:** 2019-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2018-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03666806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03666806, "Preventing Stroke Triggers in Children With Sickle Cell Anaemia in Mulago Hospital, Kampala (PREST ): a Randomized Control Trial". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03666806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*